Lifestance Health Group, Inc. Stock Price, News & Analysis

LifeStance Health Group, Inc. (NASDAQ: LFST), a leading provider of outpatient mental health care, announced that it will release its first quarter earnings on May 10, 2023, prior to market opening. The company will hold a live conference call at 8:30 a.m. Eastern Time on the same day to discuss the results. Interested parties can join the call by dialing designated numbers for domestic and international participants, using conference ID 1854301. A webcast of the call will be available on the LifeStance Investor Relations website, along with related materials. Founded in 2017, LifeStance operates around 600 centers across 34 states, employing about 5,600 mental health professionals to provide virtual and in-person care.

LifeStance Health Group, Inc. (Nasdaq: LFST) reported Q4 2022 revenue of $229.4 million, a 21% increase from the prior year, and a full-year revenue of $859.5 million, up 29%. The clinician base grew by 18% to 5,631. Despite the growth, the company recorded a net loss of $46.7 million for Q4 and $215.6 million for the full year, primarily due to stock compensation. Adjusted EBITDA was positive at $10.2 million for Q4 and $52.7 million for the full year. For 2023, LifeStance anticipates revenue between $980 million and $1.02 billion and a Center Margin of $270 to $290 million. The outlook emphasizes a focus on streamlining operations for sustainable growth.

LifeStance Health Group, Inc. (NASDAQ: LFST) will announce its fourth quarter earnings on March 8, 2023, before the market opens. A live earnings conference call will take place at 8:30 a.m. Eastern time on the same day, accessible domestically at 1-800-715-9871 or internationally at 1-646-307-1963, using conference ID 4226236. The call will be available for replay on their Investor Relations website. LifeStance, founded in 2017, is a leading provider of outpatient mental health care, offering services through approximately 600 centers in 32 states, employing around 5,400 mental health professionals.

LifeStance Health (NASDAQ: LFST), a leading provider of outpatient mental health care, has been Certified™ by Great Place to Work® for the second consecutive year. This recognition highlights the company's commitment to enhancing employee experience and workplace culture, as validated by feedback from its staff. Research indicates that employees at Certified workplaces report significantly higher job satisfaction and a fair compensation structure. LifeStance emphasizes mental wellness, financial wellness, and community engagement as key components of its corporate culture.

LifeStance Health Group (NASDAQ: LFST) announced its participation in the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, in San Francisco. The presentation will feature CEO Ken Burdick and President Danish Qureshi, starting at 7:30 a.m. Pacific time, and will be moderated by Lisa Gill. The event will be webcast live, with a replay available afterward on the company's Investor Relations website. LifeStance, founded in 2017, is a major provider of outpatient mental health care across the U.S., employing approximately 5,400 mental health professionals.

LifeStance Health Group (NASDAQ: LFST) reported Q3 2022 revenue of $217.6 million, a 25% increase from Q3 2021. The company achieved a net loss of $37.9 million, significantly improved from $120.5 million a year prior, mainly due to $34.9 million in stock-based compensation. Adjusted EBITDA rose 44% to $15.4 million. Despite expanding its clinician base by 24% to 5,431, the company adjusted its 2022 revenue guidance to $845-$850 million, citing lower visit volumes and increased costs. LifeStance continues to focus on growth and operational improvements.